Project Grant HT94252310620
Award Date
9/30/23
Completion Date
9/29/25
Dollars Obligated
$616K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
Wayne State University was awarded a $538,792 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting TINAGL1 to Enhance Immunotherapy Response in Lung Cancer." The three-year award beginning May 1, 2023 will support the university's efforts to investigate medical solutions for battlefield injuries and transform military and public health care through innovative biomedical research....
The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
The Project Grant award of $400,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund research at Wayne State University to "HARNESS IMMUNOMETABOLISM TO AMELIORATE THE PATHOLOGY OF OCULAR CHEMICAL INJURIES". The project will run from July 1, 2025 to June 30, 2027 and aims to develop innovative medical solutions to address health challenges faced by military service members. Wayne State University, a prominent public research...
This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
The U.S. Department of Defense's Defense Health Agency awarded a $643,558 Project Grant to Wright State University on August 12, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research on "IMMUNOTOXICANT EXPOSURES AND INDIVIDUALIZED IMMUNE MODULATION VIA VARIANTS" over a 3-year performance period ending on August 11, 2027. As a leading research university, Wright State University has extensive experience conducting biomedical...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
The Washington State University will receive $1,377,000 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on the novel role and therapeutic targeting of LMO4 in lethal prostate cancer from July 1, 2023 to June 30, 2026. Through this three-year Project Grant, WSU researchers will investigate medical solutions for the battlefield by exploring the oncogenic functions of LMO4 and developing targeted therapies to...